Evaluation of Safety and Effectiveness of the BioMimics 3D Stent System

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 271 participants.

Also called NCT02400905

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 271 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02400905
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Germany, Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02400905. Allocation not applicable; no masking; primary purpose treatment. Start 2015-06-29 (actual); primary completion 2017-11-03 (actual). Results posted on 2019-01-18.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Safety and Effectiveness of the BioMimics 3D Stent System
Acronym
MIMICS-2
Condition
Peripheral Arterial Disease
Intervention (Device)
BioMimics 3D Vascular Stent System
Lead sponsor
Veryan Medical Ltd. (class: industry)
Collaborator
ClinLogix. LLC (class: industry)
Collaborator
Yale Cardiovascular Research Group (class: other)
Collaborator
Massachusetts General Hospital (class: other)

Record details

Record id
cardio:ct-nct02400905
Content hash
9f54217a96e7c6999b3be99635e650f179336dc79c2406e7dc47af47caa984f1